IP Library Assignment 013824/0075
Patent Assignment
Reel/Frame 013824/0075

Assignment of Assignor's Interest

Recorded: 2003-07-23 Pages: 7
Assignors
SCHMITT, JEFFREY D.
Executed: 2003-07-10
DULL, GARY M.
Executed: 2003-07-10
GENEVOIS-BARELLA, ARIELLE
Executed: 2003-05-20
CAPET, MARC
Executed: 2003-06-12
CHEVE, MICHEL
Executed: 2003-05-20
AVENTIS PHARMA S.A.
Executed: 2003-05-20
Assignee
TARGACEPT, INC.
200 EAST FIRST STREET, SUITE 300, WINSTON-SALEM, NORTH CAROLINA, 27101
Covered Property (1)
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 7,098,331 →
Application: 10/379,868 →
Publication: US 2004/0176348
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Change of Name Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Patent Security Agreement Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Corrective Assignment to Correct the the Conveying Party Execution Date Previously Recorded at Reel: 041044 Frame: 0211. Assignor(S) Hereby Confirms the Assignment. Oct 26, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 057923/0518 →
Release of Security Interest Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →